Eculizumab Biosimilar (Complement C5 Reference Antibody)

CAT: 0013-GTR18039508-01Size: 10 mgDry Ice: NoHazardous: No

1 / 1

CAT#:0013-GTR18039508-01Size:10 mg

Selected

24/48H Stock Items & 2 to 6 Weeks non Stock Items.

Quick Request Actions

Description

Eculizumab is a long-acting humanized monoclonal antibody targeted against complement C5 and it is used to treat a number of autoimmune conditions.

Target

Eculizumab Biosimilar (Anti-Complement C5 Reference Antibody)

Clonality

Monoclonal

Conjugation

Unconjugated

Field of Research

Immunology & Inflammation

Storage Conditions

Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.

Notes

For research use only.

Related Products

Catalog	Name
GTR18622675-01	Anti-human Complement C5 (Eculizumab Biosimilar)
GTR18780635-01	(Eculizumab) Biosimilar Reference Antibody
GTR18605826-01	Anti-Complement C5 [Eculizumab]
GTR18594555-01	Lendalizumab Biosimilar (Complement C5 Reference Antibody)
GTR18118068	Eculizumab (C5) - Research Grade Biosimilar Antibody
GTR18315432	Complement C5 Reference Antibody (crovalimab)
GTR18315431	Complement C5 Reference Antibody (pozelimab)
GTR18622586-01	Anti-human Complement C5 (Crovalimab Biosimilar)
GTR18622424-01	Anti-human Complement C5 (Pozelimab Biosimilar)
GTR18622355-01	Anti-human Complement C5 (Tesidolumab Biosimilar)

Catalog	Name
RA0779-01	Brentuximab (Biosimilar Reference Antibody) (TNFRSF8)
RA0088-01	Brenetafusp (Biosimilar Reference Antibody) (CD3)
RA0365-01	Brazikumab (Biosimilar Reference Antibody) (IL23A)
RA0778-01	Boserolimab (Biosimilar Reference Antibody) (TNFRSF7)
RA0699-01	Blosozumab (Biosimilar Reference Antibody) (SOST)
RA0743-01	Adalimumab (Biosimilar Reference Antibody) (TNF)
RA0131-01	Bezetabart (Biosimilar Reference Antibody) (CD74)
RA0589-01	Zimberelimab (Biosimilar Reference Antibody) (PDCD1)
RA0788-01	Zigakibart (Biosimilar Reference Antibody) (TNFSF13)
RA0111-01	Zanolimumab (Biosimilar Reference Antibody) (CD4)